nitroglycerin has been researched along with Disease Exacerbation in 20 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seventeen patients with operable lung adenocarcinoma and stable angina pectoris were selected to investigate the effects of nitroglycerin on immunoreactivity for hypoxia-inducible factor 1alpha (HIF-1alpha), vascular endothelial growth factor (VEGF), P-glycoprotein (P-gp), the production of which is regulated by HIF-1, and p53 proteins in their resected tumor by semiquantitative immunohistochemical analyses." | 9.12 | Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma. ( Asada, M; Fuji, H; Inoue, D; Kanda, A; Kaneta, T; Kondo, T; Nakayama, K; Okinaga, S; Sasaki, H; Sasaki, T; Suzuki, S; Suzuki, T; Takai, Y; Watanabe, M; Yamanda, S; Yamaya, M; Yanagihara, K; Yasuda, H; Yoshida, M; Zayasu, K, 2006) |
| "Addition of nitroglycerine (NTG) to transcatheter arterial embolization/transarterial chemoembolization (TAE/TACE) has been shown to increase deposition of Lipiodol emulsion in hepatocellular carcinoma (HCC) tumors." | 7.88 | Nitroglycerine use in transcatheter arterial (chemo) embolization in patients with hepatocellular carcinoma: Five-year retrospective study. ( Chuang, MT; Lin, CY; Liu, YS; Ou, MC; Tsai, YS; Wang, CK, 2018) |
| "Seventeen patients with operable lung adenocarcinoma and stable angina pectoris were selected to investigate the effects of nitroglycerin on immunoreactivity for hypoxia-inducible factor 1alpha (HIF-1alpha), vascular endothelial growth factor (VEGF), P-glycoprotein (P-gp), the production of which is regulated by HIF-1, and p53 proteins in their resected tumor by semiquantitative immunohistochemical analyses." | 5.12 | Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma. ( Asada, M; Fuji, H; Inoue, D; Kanda, A; Kaneta, T; Kondo, T; Nakayama, K; Okinaga, S; Sasaki, H; Sasaki, T; Suzuki, S; Suzuki, T; Takai, Y; Watanabe, M; Yamanda, S; Yamaya, M; Yanagihara, K; Yasuda, H; Yoshida, M; Zayasu, K, 2006) |
| "Addition of nitroglycerine (NTG) to transcatheter arterial embolization/transarterial chemoembolization (TAE/TACE) has been shown to increase deposition of Lipiodol emulsion in hepatocellular carcinoma (HCC) tumors." | 3.88 | Nitroglycerine use in transcatheter arterial (chemo) embolization in patients with hepatocellular carcinoma: Five-year retrospective study. ( Chuang, MT; Lin, CY; Liu, YS; Ou, MC; Tsai, YS; Wang, CK, 2018) |
| " We used glyceryl trinitrate (nitroglycerin) to trigger premonitory symptoms and migraine headache in patients with episodic migraine without aura who habitually experienced premonitory symptoms during spontaneous attacks." | 3.80 | Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. ( Goadsby, PJ; Maniyar, FH; Monteith, T; Schankin, C; Sprenger, T, 2014) |
| "Coronary vasodilator function and atherosclerotic plaque progression have both been shown to be associated with adverse cardiovascular events." | 2.87 | Evaluation of human coronary vasodilator function predicts future coronary atheroma progression. ( Baillie, TJ; Beltrame, JF; Delacroix, S; Honda, S; Howell, S; Kim, S; Montarello, N; Nicholls, SJ; Psaltis, PJ; Shishikura, D; Sidharta, SL; Worthley, MI; Worthley, SG, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butala, NM | 1 |
| Tamez, H | 1 |
| Secemsky, EA | 1 |
| Grantham, JA | 1 |
| Spertus, JA | 1 |
| Cohen, DJ | 1 |
| Jones, P | 1 |
| Salisbury, AC | 1 |
| Arnold, SV | 1 |
| Harrell, F | 1 |
| Lombardi, W | 1 |
| Karmpaliotis, D | 1 |
| Moses, J | 1 |
| Sapontis, J | 1 |
| Yeh, RW | 1 |
| Sidharta, SL | 1 |
| Baillie, TJ | 1 |
| Howell, S | 1 |
| Nicholls, SJ | 1 |
| Montarello, N | 1 |
| Honda, S | 1 |
| Shishikura, D | 1 |
| Delacroix, S | 1 |
| Kim, S | 1 |
| Beltrame, JF | 1 |
| Psaltis, PJ | 1 |
| Worthley, SG | 1 |
| Worthley, MI | 1 |
| Liu, YS | 1 |
| Lin, CY | 1 |
| Chuang, MT | 1 |
| Tsai, YS | 1 |
| Wang, CK | 1 |
| Ou, MC | 1 |
| Abad, N | 1 |
| Rosenberg, JT | 1 |
| Hike, DC | 1 |
| Harrington, MG | 1 |
| Grant, SC | 1 |
| Figueras, J | 1 |
| Domingo, E | 1 |
| Ferreira, I | 1 |
| Lidón, RM | 1 |
| Bellera, N | 1 |
| Garcia-Dorado, D | 1 |
| Maniyar, FH | 1 |
| Sprenger, T | 1 |
| Monteith, T | 1 |
| Schankin, C | 1 |
| Goadsby, PJ | 1 |
| Hohl, M | 1 |
| Linz, D | 1 |
| Fries, P | 1 |
| Müller, A | 1 |
| Stroeder, J | 1 |
| Urban, D | 1 |
| Speer, T | 1 |
| Geisel, J | 1 |
| Hummel, B | 1 |
| Laufs, U | 1 |
| Schirmer, SH | 1 |
| Böhm, M | 1 |
| Mahfoud, F | 1 |
| Marchetti, N | 1 |
| Ciccolella, DE | 1 |
| Jacobs, MR | 1 |
| Crookshank, A | 1 |
| Gaughan, JP | 1 |
| Kashem, MA | 1 |
| Bove, AA | 1 |
| Criner, GJ | 1 |
| Sheta, MA | 1 |
| Paladugu, M | 1 |
| Mendelson, J | 1 |
| Holland, NR | 1 |
| Shlipak, MG | 1 |
| Massie, BM | 1 |
| Cake, MA | 1 |
| Read, RA | 1 |
| Appleyard, RC | 1 |
| Hwa, SY | 1 |
| Ghosh, P | 1 |
| Bisognano, JD | 1 |
| Lindenfeld, J | 1 |
| Hammond, E | 1 |
| Zisman, LS | 1 |
| Shangina, OA | 1 |
| Kostin, VI | 1 |
| Koturga, LI | 1 |
| Larsen, AI | 1 |
| Dickstein, K | 1 |
| Ahmadi, NS | 1 |
| Aarsland, T | 1 |
| Kvaløy, JT | 1 |
| Hall, C | 1 |
| Yasuda, H | 1 |
| Nakayama, K | 1 |
| Watanabe, M | 1 |
| Suzuki, S | 1 |
| Fuji, H | 1 |
| Okinaga, S | 1 |
| Kanda, A | 1 |
| Zayasu, K | 1 |
| Sasaki, T | 1 |
| Asada, M | 1 |
| Suzuki, T | 1 |
| Yoshida, M | 1 |
| Yamanda, S | 1 |
| Inoue, D | 1 |
| Kaneta, T | 1 |
| Kondo, T | 1 |
| Takai, Y | 1 |
| Sasaki, H | 1 |
| Yanagihara, K | 1 |
| Yamaya, M | 1 |
| Yee, J | 1 |
| Bhabra, MS | 1 |
| Hopkinson, DN | 1 |
| Shaw, TE | 1 |
| Hooper, TL | 1 |
| Hernandez, A | 1 |
| Barberi, L | 1 |
| Ballerio, R | 1 |
| Testini, A | 1 |
| Ferioli, R | 1 |
| Bolla, M | 1 |
| Natali, M | 1 |
| Folco, G | 1 |
| Catapano, AL | 1 |
| Ogawa, H | 1 |
| Soejima, H | 1 |
| Takazoe, K | 1 |
| Miyamoto, S | 1 |
| Kajiwara, I | 1 |
| Shimomura, H | 1 |
| Sakamoto, T | 1 |
| Yoshimura, M | 1 |
| Kugiyama, K | 1 |
| Kimura, M | 1 |
| Yasue, H | 1 |
| Ikeda, N | 1 |
| Yasu, T | 1 |
| Yamada, S | 1 |
| Ino, T | 1 |
| Saito, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Biomarker Identification to Predict the Evolution of Migraine From an Episodic to a Chronic Condition[NCT04696510] | 15 participants (Actual) | Observational | 2018-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for nitroglycerin and Disease Exacerbation
| Article | Year |
|---|---|
Evaluation of human coronary vasodilator function predicts future coronary atheroma progression.
Topics: Aged; Albuterol; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Disease Progressio | 2018 |
The effect of altering haemodynamics on the plasma concentrations of natriuretic peptides in heart failure.
Topics: Cardiac Output, Low; Cross-Over Studies; Disease Progression; Female; Humans; Male; Middle Aged; Nat | 2006 |
Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding | 2006 |
17 other studies available for nitroglycerin and Disease Exacerbation
| Article | Year |
|---|---|
Predicting Residual Angina After Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the OPEN-CTO Registry.
Topics: Angina Pectoris; Chronic Disease; Coronary Angiography; Coronary Occlusion; Disease Progression; Hum | 2022 |
Nitroglycerine use in transcatheter arterial (chemo) embolization in patients with hepatocellular carcinoma: Five-year retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined | 2018 |
Dynamic sodium imaging at ultra-high field reveals progression in a preclinical migraine model.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Disease Progression; Dose-Response Relationsh | 2018 |
Typical angina without significant coronary stenosis: comparison of clinical profile, circadian presentation, and long-term follow-up between patients with and patients without vasospastic angina.
Topics: Adult; Chi-Square Distribution; Circadian Rhythm; Coronary Angiography; Coronary Vasospasm; Diabetes | 2013 |
Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks.
Topics: Adult; Brain; Cerebrovascular Circulation; Data Interpretation, Statistical; Disease Progression; Fe | 2014 |
Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient rats.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Pressure; Body Weight; Carbachol; Denervat | 2016 |
Hospitalized acute exacerbation of COPD impairs flow and nitroglycerin-mediated peripheral vascular dilation.
Topics: Aged; Aged, 80 and over; Brachial Artery; Disease Progression; Female; Forced Expiratory Volume; Hos | 2011 |
When should nitroglycerine be avoided in hypertensive encephalopathy?
Topics: Contraindications; Disease Progression; Follow-Up Studies; Humans; Hypertensive Encephalopathy; Infu | 2011 |
The clinical challenge of cardiorenal syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Case Management; Cohort Studies; Creatinine; Disease Progr | 2004 |
The nitric oxide donor glyceryl trinitrate increases subchondral bone sclerosis and cartilage degeneration following ovine meniscectomy.
Topics: Animals; Biomechanical Phenomena; Bone and Bones; Cartilage, Articular; Disease Progression; Female; | 2004 |
Coronary artery vasospasm causing acute myocardial infarction in a heart transplant recipient.
Topics: Acute Disease; Coronary Angiography; Coronary Vasospasm; Disease Progression; Graft Rejection; Heart | 2005 |
[Effects of therapy with various groups of antianginal agents on life quality of the elderly with coronary heart disease and comorbid depression].
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Atenolol; Calcium Channel Blockers; Depression; Dise | 2005 |
Chronic kidney disease--a disease domain complex.
Topics: Aged; Alendronate; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Asp | 2008 |
Attenuation of lung graft reperfusion injury by a nitric oxide donor.
Topics: Animals; Cardioplegic Solutions; Disease Models, Animal; Disease Progression; Hemodynamics; Hydralaz | 1997 |
Delapril slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Aorta, Thoracic; Arterioscleros | 1998 |
Increased autoantibodies against oxidized low-density lipoprotein in coronary circulation in patients with coronary spastic angina.
Topics: Acetylcholine; Administration, Sublingual; Adult; Aged; Angina Pectoris, Variant; Autoantibodies; Bi | 2001 |
Echocardiographical demonstration of a progressively expanding left ventricular aneurysm preceded by endomyocardial tearing.
Topics: Aged; Aneurysm, False; Antihypertensive Agents; Combined Modality Therapy; Coronary Disease; Disease | 2001 |